EBOS Group (ASX:EBO) Pairs Its Final Dividend With Continued Healthcare Expansion

Aditi Sarkar

26 August 2026 04:29 PM AEST

EBOS Group (ASX:EBO) Pairs Its Final Dividend With Continued Healthcare Expansion

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

EBOS Group Ltd (ASX:EBO) is scheduled to trade ex-dividend on 27 August 2026.
The final distribution is AUD 0.448 per security, with 97% franking, and payment is scheduled for 18 September 2026.
At the provided price of AUD 18.37, the stated Dividend yield is 2.44%.
EBOS presented its FY26 full-year results on 19 August 2026.

EBOS Group Ltd (ASX:EBO) is approaching its next ex-dividend date with income investors focused on both the upcoming distribution and the operating backdrop supporting it. As of 26 August 2026, the security was priced at AUD 18.37, while the upcoming final payment is AUD 0.448 per security. With the ex-date set for 27 August 2026 and payment scheduled for 18 September 2026, the dividend timetable arrives alongside recent company reporting that provides a clearer view of earnings, Cash Flow and the capacity for future distributions.

EBO Dividend: Key Dates and Payment Details

The upcoming final distribution is AUD 0.448 per security and carries 97% franking. The security is due to trade ex-dividend on 27 August 2026, meaning buyers from that date would generally not be entitled to this declared payment. The scheduled payment date is 18 September 2026.

Based on the supplied price of AUD 18.37, the stated yield for this payment is 2.44%. Dividend Yield alone does not determine total return, but it can be useful when considered alongside Earnings quality, cash generation, balance-sheet capacity and the company’s broader distribution policy.

Recent Company Update

EBOS presented its FY26 full-year results on 19 August 2026.

Earlier HY26 Revenue rose 13% to about AUD 6.77 billion and underlying EBITDA increased 3.2% to AUD 300 million.

The group has been investing in distribution-centre renewal, retail pharmacy and medical technology while maintaining animal-care growth initiatives.

Why the Latest Update Matters for the Dividend

A dividend becomes more meaningful when it is considered against the Business performance behind it. Earnings, cash conversion, balance-sheet flexibility and Capital requirements all influence whether a company can maintain, increase or reduce future payments. Recent results therefore provide context for the current distribution rather than serving as a guarantee of future dividends.

Distribution-centre productivity, healthcare volumes, animal-care product growth, cash-flow improvement and deleveraging are key measures for the next period.

What Could Drive the Shares and Dividend Next?

Distribution-centre productivity, healthcare volumes, animal-care product growth, cash-flow improvement and deleveraging are key measures for the next period.

The next reporting period will provide another test of whether current operating trends are converting into sustainable cash generation. Investors are also likely to watch any changes to capital allocation, payout policy, Debt levels and forward guidance.

Key Risks to Watch

Healthcare reimbursement settings, customer concentration, integration, capital intensity, supply-chain execution and funding costs can affect performance.

Dividends and distributions are not guaranteed. Boards can change payout decisions as earnings, capital needs, regulatory requirements or market conditions evolve. The share price can also adjust around the ex-dividend date and for reasons unrelated to the cash payment itself.

EBOS Group Ltd Dividend Outlook

The upcoming AUD 0.448 final distribution gives EBOS Group Ltd shareholders a defined near-term income event, with 97% franking and payment due on 18 September 2026. Beyond that payment, the more important question is whether operating performance can support the next distribution cycle. Distribution-centre productivity, healthcare volumes, animal-care product growth, cash-flow improvement and deleveraging are key measures for the next period. Continued progress would improve visibility over future income, while weaker earnings or higher capital demands could alter the payout profile.

FAQs

Q: When does EBOS Group Ltd trade ex-dividend?

A: The ex-dividend date in the provided data is 27 August 2026.

Q: How much is the EBO dividend?

A: The declared final distribution is AUD 0.448 per security.

Q: When is the EBO dividend paid?

A: Payment is scheduled for 18 September 2026.

Q: Is the EBO dividend franked?

A: The distribution carries 97% franking.

Q: What could influence future EBO dividends?

A: Distribution-centre productivity, healthcare volumes, animal-care product growth, cash-flow improvement and deleveraging are key measures for the next period.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.